Logiscreen

Illumina Inc

$162.32
Market Cap 24.82B
ROE 34.0%
Gross Margin 66.1%
Debt/Equity 0.9
Current Ratio 1.7
Revenue QoQ 4.8%
EPS QoQ 0.1%
F-Score 4

About

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
30.12
vs median 33.61
P/B
9.60
vs median 2.16
ROE
0.34
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics